NASDAQ Composite opens in less than one hour and Catalyst Pharmaceuticals’s premarket value is already 2.92% up.
The last session, nASDAQ Composite ended with Catalyst Pharmaceuticals sliding 0% to $3.42. NASDAQ Composite jumped 0.26% to $12,804.73, following last session’s upward trend on what was a somewhat positive trend exchanging session.
Catalyst Pharmaceuticals’s last close was $3.42, 54.39% below its 52-week high of $5.28.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.